MBIO
$0.85-0.00 (-0.27%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.
$0.85-0.00 (-0.27%)
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases.